October 24, 2024
TOPLINE: Increases in prescriptions for both glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter 2 (SGLT2) inhibitors were observed in patients with type 1 […]
October 24, 2024
TOPLINE: A recent study found that long-term exposure to fine particulate matter ≤ 2.5 μm (PM2.5) is associated with an increased risk for breast cancer, with […]
October 24, 2024
TOPLINE: A 48-week oral semaglutide treatment regimen for type 2 diabetes (T2D) reduces weight and improves liver steatosis, liver stiffness, and liver enzyme levels in patients […]
October 24, 2024
TOPLINE: The use of a levonorgestrel-releasing intrauterine system (LNG-IUS) is associated with an increased risk for breast cancer. An analysis by Danish researchers found 14 extra […]
October 24, 2024
TOPLINE: Disparities in emergency department (ED) mortality and patient outcomes after cardiac arrest in the United States emphasize an urgent need for equitable healthcare resources and […]
October 24, 2024
TOPLINE: In critically ill patients, video laryngoscopy offers superior glottic visualization, reduces the incidence of esophageal intubation, and improves the first-attempt success rate of emergency tracheal […]
October 24, 2024
TOPLINE: Mepivacaine instillation significantly reduced pain during intrauterine device (IUD) placement in nulliparous women. More than 90% of women in the intervention group reported tolerable pain […]
October 23, 2024
TOPLINE: A greater percentage of counties with the highest cancer mortalities had no trials vs counties with the lowest cancer mortalities. No trials occurred in 85% […]
October 23, 2024
TOPLINE: Compared with six cycles, three cycles of chemotherapy for high-risk retinoblastoma showed noninferior 5-year disease-free survival (DFS). The three-cycle regimen also resulted in fewer adverse […]